Company / Interest Expense per Share
Corbus Pharmaceuticals Holdings, Inc. Interest Expense per Share History
FY2015-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.65
FY2022
5-year range
$0.00 / $0.65
FY2018-FY2022
Trend
+5601.1%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense per Share changed +5601% YoY in FY2022, a notable deviation from the 4-year average annual change of +1352%.
Based on SEC 10-K filings.
0.65 in FY2022 with a 5-year CAGR of +531.1%.
Increased from $0.00 to $0.65 over the past 2 years.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +531.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, interest expense per share increased 5601.1% year-over-year.
- Lowest interest expense per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -12.48 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $0.65 | +5601.1% |
| FY2021 | $0.01 | - |
| FY2020 | $0.00 | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | $0.00 | +0.0% |
| FY2016 | $0.00 | -93.0% |
| FY2015 | $0.00 | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026